CRP and bacterial infectious disease with sepsis: Moreover, Siegele and colleagues demonstrated that CRP activates the classical complement pathway (44, 45) the administration of human CRP has been found to be protective against pneumococcal infection in mouse models, highlighting the role of CRP in reducing bacteremia and promoting survival in infected murine models (46).